Berlin, Germany

Agnes Muehlenweg

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Technische Unversität Berlin. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Agnes Muehlenweg: Innovator in Microbial Metabolite Production

Introduction

Agnes Muehlenweg is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of microbial biotechnology, particularly in the production of chimeric cyclooligodepsipeptides. Her innovative work has implications for various applications in pharmaceuticals and biotechnology.

Latest Patents

Agnes holds a patent titled "Process for producing chimeric cyclooligodepsipeptides in filamentous fungi." This patent describes a method for obtaining at least one microbial secondary metabolite or a derivative thereof. The method includes the step of heterologous expression of at least one synthetase of the secondary metabolite in at least one filamentous fungus. Additionally, the patent discloses an expression cassette, a plasmid vector including the expression cassette, an expression host, cyclodepsipeptides, and a chimeric cyclodepsipeptide synthetase. She has 1 patent to her name.

Career Highlights

Agnes Muehlenweg is affiliated with Technische Universität Berlin, where she conducts her research and development activities. Her work has garnered attention for its innovative approach to microbial metabolite production, showcasing her expertise in the field.

Collaborations

Agnes collaborates with notable colleagues, including Vera Meyer and Simon Boecker. Their combined efforts contribute to advancing research in microbial biotechnology and enhancing the understanding of secondary metabolite production.

Conclusion

Agnes Muehlenweg is a trailblazer in the field of microbial biotechnology, with her innovative patent paving the way for future advancements. Her contributions are vital for the development of new biotechnological applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…